Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Marina G.D. Leed"'
Autor:
James E. Huckle, Matthew P. Sadgrove, Yu Tsai Yang, Michael Jay, Richard C. Semelka, Russell J. Mumper, Marina G.D. Leed
Publikováno v:
The AAPS Journal. 18:972-980
The increasing threats of nuclear terrorism have made the development of medical countermeasures a priority for international security. Injectable formulations of diethylenetriaminepentaacetic acid (DTPA) have been approved by the FDA; however, an or
The pentaethyl ester prodrug of the chelating agent diethylene triamine pentaacetic acid (DTPA) referred to as C2E5 is being developed as an orally bioavailable radionuclide decorporation agent. The predicted human efficacy obtained in these experime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6dd0050c8ef2a2747526fa91798e05a
https://europepmc.org/articles/PMC4781669/
https://europepmc.org/articles/PMC4781669/
Autor:
Russell J. Mumper, Robert L. Susick, Michael Jay, Bushra J. Agha, Erik Pacyniak, Melanie Doyle-Eisele, James E. Huckle, Raymond A. Guilmette, Matthew P. Sadgrove, Marina G.D. Leed, Waylon Weber
Publikováno v:
International journal of radiation biology. 91(7)
Currently two injectable products of diethylenetriaminepentaacetic acid (DTPA) are U.S. Food and Drug Administration (FDA)-approved for decorporation of (241)Am; however, an oral product is considered more amenable in a mass casualty situation. The d
Autor:
Michael Jay, Waylon Weber, Melanie Doyle-Eisele, Katsuhiko Sueda, James E. Huckle, Matthew P. Sadgrove, Marina G.D. Leed, Raymond A. Guilmette
Diethylenetriaminepentaacetic acid (DTPA) is an effective decorporation agent to facilitate the elimination of radionuclides from the body, but its permeability-limited oral bioavailability limits its utility in mass-casualty emergencies. To overcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a067bcdd9887aba306ae700e4ff34848
https://europepmc.org/articles/PMC4001124/
https://europepmc.org/articles/PMC4001124/
Autor:
Marina G.D. Leed, Catheleeya Mekjaruskul, Matthew P. Sadgrove, Yu Tsai Yang, Michael Jay, Bungorn Sripanidkulchai
Publikováno v:
International journal of pharmaceutics. 445(1-2)
The Kaempferia parviflora (KP) plant contains several methoxyflavones including 5,7-dimethoxyflavone (DMF), 5,7,4'-trimethoxyflavone (TMF), and 3,5,7,3',4'-pentamethoxyflavone (PMF). Ethanolic extracts of KP have shown various pharmacological effects